Last updated: 18 December 2023 at 5:12pm EST

John Herrmann Net Worth




The estimated Net Worth of John A Iii Herrmann is at least $6.7 Million dollars as of 14 December 2023. Mr. Herrmann owns over 2,100 units of Novavax stock worth over $171,237 and over the last 10 years he sold NVAX stock worth over $5,173,360. In addition, he makes $1,353,420 as Executive Vice President and Chief Legal Officer at Novavax.

Mr. Herrmann NVAX stock SEC Form 4 insiders trading

John has made over 42 trades of the Novavax stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 2,100 units of NVAX stock worth $25,809 on 14 December 2023.

The largest trade he's ever made was exercising 46,242 units of Novavax stock on 18 August 2020 worth over $2,488,744. On average, John trades about 5,987 units every 61 days since 2014. As of 14 December 2023 he still owns at least 13,933 units of Novavax stock.

You can see the complete history of Mr. Herrmann stock trades at the bottom of the page.





John Herrmann biography

John A. Herrmann III serves as Executive Vice President, Chief Legal Officer of the Company. He has served as Senior Vice President, General Counsel and Corporate Secretary since June 2014. He previously served as the Company’s Vice President, General Counsel and Corporate Secretary from March 2012 to June 2014, and its Executive Director, Legal Affairs and Corporate Secretary from April 2010 to March 2012. Prior to joining the Company, Mr. Herrmann was General Counsel at Ore Pharmaceuticals and Deputy General Counsel at Gene Logic before it became Ore Pharmaceuticals. Mr. Herrmann worked as Senior Counsel for Celera Genomics following his position as Senior Corporate Counsel at Baxter Healthcare in its Renal Division. Mr. Herrmann received a B.A. in political science and history from Brown University and a J.D. from the University of Illinois.

What is the salary of John Herrmann?

As the Executive Vice President and Chief Legal Officer of Novavax, the total compensation of John Herrmann at Novavax is $1,353,420. There are 3 executives at Novavax getting paid more, with Stanley Erck having the highest compensation of $2,438,560.



How old is John Herrmann?

John Herrmann is 54, he's been the Executive Vice President and Chief Legal Officer of Novavax since 2020. There are 16 older and 4 younger executives at Novavax. The oldest executive at Novavax, Inc. is Michael McManus, 77, who is the Independent Director.

What's John Herrmann's mailing address?

John's mailing address filed with the SEC is C/O NOVAVAX, INC., 21 FIRSTFIELD ROAD, GAITHERSBURG, MD, 20878.

Insiders trading at Novavax

Over the last 23 years, insiders at Novavax have traded over $136,088,511 worth of Novavax stock and bought 2,908,869 units worth $5,634,467 . The most active insiders traders include David M Mott, Rajiv I. Modi, and Gary C Evans. On average, Novavax executives and independent directors trade stock every 25 days with the average trade being worth of $907,678. The most recent stock trade was executed by John Trizzino on 19 August 2024, trading 655 units of NVAX stock currently worth $8,050.



What does Novavax do?

novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. product pipeline our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus ("rsv"​), seasonal influenza, pandemic influenza, and ebola virus ("ebov"​). we have additional preclinical-stage programs for a variety of infectious diseases. corporate overview novavax is headquartered in gaithersburg, maryland with additional facilities in rockville, maryland and uppsala, sweden. novavax is traded on the nasdaq stock market under the symbol nvax and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease.



Complete history of Mr. Herrmann stock trades at Novavax

Insider
Trans.
Transaction
Total value
John A Iii Herrmann
EVP and Chief Legal Officer
Option $11,949
14 Dec 2023
John A Iii Herrmann
EVP and Chief Legal Officer
Option $5,581
25 Jun 2023
John A Iii Herrmann
EVP and Chief Legal Officer
Option $30,051
10 Mar 2023
John A Iii Herrmann
EVP and Chief Legal Officer
Option $36,183
14 Dec 2022
John A Iii Herrmann
EVP and Chief Legal Officer
Option $87,557
26 Sep 2022
John A Iii Herrmann
EVP and Chief Legal Officer
Option $74,140
24 Aug 2022
John A Iii Herrmann
EVP and Chief Legal Officer
Option $43,041
25 Jun 2022
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
3 Jan 2022
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
20 Dec 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $353,703
14 Dec 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
1 Dec 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
29 Nov 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
3 Nov 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
1 Nov 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
1 Oct 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $1,151,214
26 Sep 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
15 Sep 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $95,400
1 Sep 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $466,020
24 Aug 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $42,948
26 Jul 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $42,948
30 Jun 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $158,285
25 Jun 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $42,933
28 May 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $42,904
30 Apr 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $42,889
26 Mar 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $42,904
26 Feb 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Option $272,649
1 Feb 2021
John A Iii Herrmann
EVP and Chief Legal Officer
Sale $4,664,714
28 Sep 2020
John A Iii Herrmann
EVP and Chief Legal Officer
Option $3,960,178
26 Sep 2020
John A Iii Herrmann
EVP and Chief Legal Officer
Option $2,488,744
18 Aug 2020
John A Iii Herrmann
EVP and Chief Legal Officer
Option $339,449
18 May 2020
John A Iii Herrmann
EVP and Chief Legal Officer
Option $5,604
8 Mar 2020
John A Iii Herrmann
EVP and Chief Legal Officer
Sale $25,756
17 Sep 2019
John A Iii Herrmann
EVP and Chief Legal Officer
Option $27,132
8 Sep 2019
John A Iii Herrmann
EVP and Chief Legal Officer
Buy $5,555
31 Jan 2017
John A Iii Herrmann
EVP and Chief Legal Officer
Buy $9,075
31 Jan 2016
John A Iii Herrmann
EVP and Chief Legal Officer
Buy $9,075
31 Jan 2016
John A Iii Herrmann
EVP and Chief Legal Officer
Sale $241,445
16 Dec 2015
John A Iii Herrmann
EVP and Chief Legal Officer
Sale $241,445
16 Dec 2015
John A Iii Herrmann
EVP and Chief Legal Officer
Buy $3,425
31 Jul 2015
John A Iii Herrmann
EVP and Chief Legal Officer
Buy $22,501
31 Jan 2015
John A Iii Herrmann
EVP and Chief Legal Officer
Buy $20,406
31 Jul 2014


Novavax executives and stock owners

Novavax executives and other stock owners filed with the SEC include: